TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients-Reference-Cited by-同舟云学术

TCL1A gene involvement in T-cell prolymphocytic leukemia in Japanese patients

Published:2011-12-23 Issue:1 Volume:95 Page:77-85
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yokohama Akihiko,Saitoh Akio,Nakahashi Hirotaka,Mitsui Takeki,Koiso Hiromi,Kim Yoshitora,Uchiumi Hideki,Saitoh Takayuki,Handa Hiroshi,Jimbo Takahiro,Murayama Kayoko,Sakura Tohru,Murakami Hirokazu,Karasawa Masamitsu,Nojima Yoshihisa,Tsukamoto Norifumi

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-011-0986-5.pdf

Reference36 articles.

1. Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, et al. Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia. Blood. 1991;78:3269–74.

2. Hoyer JD, Ross CW, Li CY, Witzig TE, Gascoyne RD, Dewald GW, et al. True T-cell chronic lymphocytic leukemia: a morphologic and immunophenotypic study of 25 cases. Blood. 1995;86:1163–9.

3. Garand R, Goasguen J, Brizard A, Buisine J, Charpentier A, Claisse JF, et al. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Francais d’Hematologie Cellulaire. Br J Haematol. 1998;103:488–94.

4. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328–35.

5. Herling M, Patel KA, Teitell MA, Konopleva M, Ravandi F, Kobayashi R, et al. High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia. Blood. 2008;111:328–37.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Genetic Diagnostic Approaches of Hematopoietic Disorders of the Spleen and Liver;Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver;2020

2. Exploring the molecular pathogenesis associated with T‑cell prolymphocytic leukemia based on a comprehensive bioinformatics analysis;Oncology Letters;2018-05-02

3. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia;Journal of Clinical Pathology;2017-08-18

4. Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling;Leukemia;2017-08-14

5. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified;European Journal of Haematology;2017-03-03